ImmusanT, a biotechnology company focusing on protecting patients with celiac disease against the effects of gluten, has announced that it has secured $40 million in funding to advance its drug, Nexvax2®, into a Phase II clinical trial. Nexvax2 is a therapeutic vaccine designed to stimulate immune tolerance in patients with celiac disease. Nexvax2® is the […]
On October 21, 2017, the Celiac Disease Foundation (CDF) held a Patient Advocacy Program workshop at the University of Chicago Celiac Disease Center’s Annual Celiac Education Day. Historically, medical research has not tapped the expertise of patients in the design and development of new treatments, often leading to disconnects between therapeutic outcomes and real patient […]
For many patients living with celiac disease or non-celiac gluten/wheat sensitivity, the emergence of almost any new or recurring symptom, even when adhering to a gluten-free diet as instructed, causes anxiety and distress. A new self-administered, home test kit called Gluten Detective, released under license by Glutenostics LLC and developed by a Spanish company, empowers patients […]
Lately, it seems as though gluten is being blamed for a vast host of ailments – everything from irritable bowel syndrome (IBS) to attention-deficit disorder – with an ever increasing number of people seeking relief through a gluten-free diet. While this strict regimen is absolutely critical for people with a confirmed diagnosis of celiac disease, […]
In the August 15, 2017 issue of the esteemed Journal of the American Medical Association, a spotlight was cast on celiac disease and non-celiac gluten sensitivity, with a comprehensive review of the current state of diagnostics, treatment, and prognosis. Celiac disease affects approximately 1% of the population worldwide. It is not yet exactly understood why […]
ImmusanT, a clinical-stage company developing Nexvax2®, a therapeutic vaccine intended to protect against the effects of gluten exposure while maintaining a gluten-free diet, presented data at the 2017 International Celiac Disease Symposium (ICDS) in Delhi, India for a potential blood test that could detect celiac disease with a single gluten challenge. This blood test could also […]
